药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Hexobarbital
Saruplase
The risk or severity of bleeding can be increased when Saruplase is combined with Nintedanib.
Hexobarbital
Melagatran
The risk or severity of bleeding can be increased when Melagatran is combined with Nintedanib.
Hexobarbital
Tioclomarol
The risk or severity of bleeding can be increased when Tioclomarol is combined with Nintedanib.
Hexobarbital
Diphenadione
The risk or severity of bleeding can be increased when Diphenadione is combined with Nintedanib.
Hexobarbital
Clorindione
The risk or severity of bleeding can be increased when Clorindione is combined with Nintedanib.
Hexobarbital
Brinase
The risk or severity of bleeding can be increased when Brinase is combined with Nintedanib.
Hexobarbital
Protein S human
The risk or severity of bleeding can be increased when Protein S human is combined with Nintedanib.
Hexobarbital
Fluindione
The risk or severity of bleeding can be increased when Fluindione is combined with Nintedanib.
Hexobarbital
Gabexate
The risk or severity of bleeding can be increased when Gabexate is combined with Nintedanib.
Hexobarbital
Monteplase
The risk or severity of bleeding can be increased when Monteplase is combined with Nintedanib.
Hexobarbital
Nafamostat
The risk or severity of bleeding can be increased when Nafamostat is combined with Nintedanib.
Hexobarbital
Betrixaban
The risk or severity of bleeding can be increased when Betrixaban is combined with Nintedanib.
Hexobarbital
Darexaban
The risk or severity of bleeding can be increased when Darexaban is combined with Nintedanib.
Hexobarbital
Letaxaban
The risk or severity of bleeding can be increased when Letaxaban is combined with Nintedanib.
Hexobarbital
Antithrombin III human
The risk or severity of bleeding can be increased when Antithrombin III human is combined with Nintedanib.
Hexobarbital
Protein C
The risk or severity of bleeding can be increased when Protein C is combined with Nintedanib.
Hexobarbital
Antithrombin Alfa
The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Nintedanib.
Hexobarbital
Zinc citrate
The risk or severity of bleeding can be increased when Zinc citrate is combined with Nintedanib.
Hexobarbital
Desirudin
The risk or severity of bleeding can be increased when Desirudin is combined with Nintedanib.
Hexobarbital
Parnaparin
The risk or severity of bleeding can be increased when Parnaparin is combined with Nintedanib.